LintonPharm To Release Data On Catumaxomab For Advanced Gastric Cancer With Peritoneal Metastasis At 2022 ASCO Annual Meeting
GUANGZHOU, China, May 30 (Bernama-BUSINESS WIRE) — LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary results of Catumaxomab for advanced Gastric Cancer (GC) with peritoneal metastasis is published online at the 2022 American Society of Clinical…

